News

6.09.17 | ECJ Intel Judgment reinstates the effects-based approach to Article 102

Following AG Wahl’s opinion in Intel in October 2016, economists dared to dream that an effects-based approach to 102 enforcement...

10.08.17 | CMA finds no grounds for action in Unilever impulse ice cream package offers investigation

CRA, along with Linklaters LLP, advised Unilever in respect of the CMA investigation into Unilever’s “package offers” (retailer promotions of...

14.07.17 | Ofcom decides not to impose changes to triple-play switching process

In July 2016, Ofcom proposed changing the switching process for consumers switching landline, broadband and/or pay TV services between the...

10.07.17 | Dutch ACM closes investigation into FOX Sports Netherlands media rights

Dutch competition authority ACM has closed its investigation into Fox’s new contract terms with pay TV distributors for the supply...

29.06.17 | Commitments accepted in online auction platforms antitrust investigation

The CMA has accepted final commitments from ATG Media to address competition concerns relating to whether ATG abused a dominant...

12.05.17 | EC approves merger of chemical producers Reichhold and Polynt

The European Commission has conditionally approved the merger of Reichhold and Polynt, which both produce unsaturated polyester resin. In order...

7.04.17 | European Commission approves 21CF/Sky transaction unconditionally

The European Commission today approved unconditionally the merger of 21st Century Fox and Sky. The transaction did not raise horizontal...

8.03.17 | UK Competition Appeals Tribunal upholds CMA decision to prohibit ICE/TRAYPORT

The CAT upheld yesterday the CMA’s decision to prohibit ICE’s acquisition of the energy and commodities trading platform Trayport. The...

8.03.17 | General Court annuls the EC’s decision to prohibit UPS’ proposed acquisition of TNT

The General Court annulled yesterday the European Commission’s decision in 2013 to prohibit UPS' proposed acquisition of TNT.  The judgment...

25.01.17 | Abbott/Alere cleared by EC, subject to conditions

The European Commission has approved Abbott’s acquisition of Alere in Phase I, subject to divestments in point-of-care testing of blood...

Media